MeSH Review:
Moraxella (Branhamella) catarrhalis
- Antibacterial activity of ticarcillin in the presence of clavulanate potassium. Sutherland, R., Beale, A.S., Boon, R.J., Griffin, K.E., Slocombe, B., Stokes, D.H., White, A.R. Am. J. Med. (1985)
- Fluoroquinolone (Lomefloxacin) International Surveillance Trial: a report of 30 months of monitoring in vitro activity. Jones, R.N. Am. J. Med. (1992)
- Multiresistance plasmid from commensal Neisseria strains. Pintado, C., Salvador, C., Rotger, R., Nombela, C. Antimicrob. Agents Chemother. (1985)
- Genetic basis of tetracycline resistance in Moraxella (Branhamella) catarrhalis. Roberts, M.C., Brown, B.A., Steingrube, V.A., Wallace, R.J. Antimicrob. Agents Chemother. (1990)
- Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria. Wakebe, H., Mitsuhashi, S. Antimicrob. Agents Chemother. (1992)
- Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid. Ninane, G., Joly, J., Kraytman, M., Piot, P. Lancet (1978)
- Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. Wallace, R.J., Nash, D.R., Steingrube, V.A. Am. J. Med. (1990)
- Antibody response to P-protein in patients with Branhamella catarrhalis infections. Chi, D.S., Verghese, A., Moore, C., Hamati, F., Berk, S.L. Am. J. Med. (1990)
- Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis. Bhushan, R., Kirkham, C., Sethi, S., Murphy, T.F. Infect. Immun. (1997)
- Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis. Bootsma, H.J., van Dijk, H., Verhoef, J., Fleer, A., Mooi, F.R. Antimicrob. Agents Chemother. (1996)
- Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitors. Farmer, T., Reading, C. Drugs (1986)
- Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents. Doern, G.V., Tubert, T. Antimicrob. Agents Chemother. (1987)
- Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis. Brown, B.A., Wallace, R.J., Flanagan, C.W., Wilson, R.W., Luman, J.I., Redditt, S.D. Antimicrob. Agents Chemother. (1989)
- In vitro susceptibilities of common pediatric pathogens to LY163892. Shelton, S., Nelson, J.D. Antimicrob. Agents Chemother. (1988)
- Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin. Neu, H.C., Chin, N.X., Labthavikul, P. Antimicrob. Agents Chemother. (1984)
- Penicillinase-producing Neisseria gonorrhoeae in the Netherlands: epidemiology and genetic and molecular characterization of their plasmids. van Embden, J.D., van Klingeren, B., Dessens-Kroon, M., van Wijngaarden, L.J. Antimicrob. Agents Chemother. (1980)
- Evaluation of Bacto TB hydrolysis reagent (Tween 80) for the identification of Branhamella catarrhalis. Weiner, M., Penha, P.D. J. Clin. Microbiol. (1990)
- The human I alpha 1 and I alpha 2 germline promoter elements: proximal positive and distal negative elements may regulate the tissue specific expression of C alpha 1 and C alpha 2 germline transcripts. Lars, N., Paschalis, S. Int. Immunol. (1993)
- Lack of immunoglobulin A1 protease production by Branhamella catarrhalis. McLeod, D.T., Croughan, M.J., Ahmad, F., Brettle, R.P., Calder, M.A. Infect. Immun. (1986)
- Effect of ampicillin, cefmetazole and minocycline on the adherence of Branhamella catarrhalis to pharyngeal epithelial cells. Ahmed, K., Matsumoto, K., Rikitomi, N., Nagatake, T., Yoshida, T., Watanabe, K. Tohoku J. Exp. Med. (1990)
- Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan. Suzuki, K., Nishimura, T., Baba, S. J. Infect. Chemother. (2003)
- Receptors for human plasminogen on gram-negative bacteria. Ullberg, M., Kronvall, G., Karlsson, I., Wiman, B. Infect. Immun. (1990)
- A membrane-bound precursor beta-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 beta-lactamases. Steingrube, V.A., Wallace, R.J., Beaulieu, D. J. Antimicrob. Chemother. (1993)
- Use of the API NeIdent system for identification of pathogenic Neisseria spp. and Branhamella catarrhalis. Janda, W.M., Morello, J.A., Bohnhoff, M. J. Clin. Microbiol. (1984)
- Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimethoprim. Riley, T.V., Digiovanni, C., Hoyne, G.F. J. Antimicrob. Chemother. (1987)
- Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Edebrink, P., Jansson, P.E., Rahman, M.M., Widmalm, G., Holme, T., Rahman, M., Weintraub, A. Carbohydr. Res. (1994)